Absci (ABSI) Non Operating Income (2020 - 2026)

Absci (ABSI) reported Non Operating Income of $1.3 million for Q1 2026, down 8.27% on a YoY basis from $1.4 million in Q1 2025, and down 3.95% sequentially from $1.3 million in Q4 2025.

Absci (ABSI) Non Operating Income (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Non Operating Income data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 8.27% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 10.66% YoY), and the FY2025 full-year result was $5.2 million, down 11.09% from the prior year.
  • Non Operating Income slipped to $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.0 million in Q2 2024 to a low of -$70000.0 in Q1 2022.
  • A 5-year average of $1.1 million and a median of $1.3 million in 2026 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income jumped 9450.0% in 2022 and slumped 51.55% in 2025, its largest moves.
  • Tracing ABSI's Non Operating Income over 5 years: stood at $1.1 million in 2022, then rose by 10.7% to $1.2 million in 2023, then tumbled by 34.62% to $812000.0 in 2024, then jumped by 62.19% to $1.3 million in 2025, then retreated by 3.95% to $1.3 million in 2026.
  • Business Quant data shows ABSI's Non Operating Income at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Absci 1.16 Bn 1.03 Bn - 1.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.27 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 1.55 Mn
Jun 30, 2025 955,000.00
Mar 31, 2025 1.38 Mn
Dec 31, 2024 812,000.00
Sep 30, 2024 1.53 Mn
Jun 30, 2024 1.97 Mn
Mar 31, 2024 1.54 Mn
Dec 31, 2023 1.24 Mn
Sep 30, 2023 1.34 Mn
Jun 30, 2023 1.33 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 1.12 Mn
Sep 30, 2022 396,000.00
Jun 30, 2022 -63,000.00
Mar 31, 2022 -70,000.00
Dec 31, 2021 -12,000.00
Sep 30, 2021 -4.20 Mn
Jun 30, 2021 -30.12 Mn